European Pharma Days 2024 - 23.4. and 24.4.2024
Bruker's, CeMOS's and M2Aind's 5th Mass Spectrometry Innovations in Pharma Meeting
Join Bruker for the annual European Pharma Meeting taking place on April 23rd - 24th 2024 organized by Bruker, M2Aind and CeMOS – Center for Mass Spectrometry and Optical Spectroscopy.
In this exciting 2-day event we have speakers from the pharmaceutical industry and academia discussing with you their strategies in Drug Targeting Approaches, Biomarker Discovery and Biopharmaceutical Characterization.
Take advantage of the opportunity to find out about the newest insights in the field of Metabolomics, Proteomics, MALDI Imaging and drug discovery. Do not miss the state-of-the-art scientific research presentations by Bruker customers.
The 2-day event is held in a safe, comfortable environment where you can meet and learn from the leading scientist in the pharmaceutical industry and academia. There is plenty of time for networking and discussion during the breaks, where you can engage with our partners in the exhibition area.
Reserve your free seat by clicking the registration link below.
Where: MAFINEX Technologiezentrum, 68163 Mannheim, Germany.
Please click here for more information.
European Pharma Days 2023 - 25.4. and 26.4.2023
Bruker's, CeMOS's and M2Aind's 4th Mass Spectrometry Innovations in Pharma Meeting
Join Bruker for the annual European Pharma Meeting taking place on April 25th - 26th 2023 in Mannheim, Germany, organized by Bruker, M2Aind and CeMOS – Center for Mass Spectrometry and Optical Spectroscopy.
In this exciting 2-day in-person event we have speakers from the pharmaceutical industry and academia discussing with you their strategies in Drug Targeting Approaches (day 1) and Biomarker Discovery & Characterization (day 2).
Emerging topics in the field of Targeted Protein Degraders, SpatialOMx®, and MALDI Imaging will be presented by Bruker customers: we welcome Prof. Dr. Martina Marchetti-Deschmann (Technical University Vienna), Prof. Dr. Rob Vreeken (Janssen Pharmaceutica), Dr. Oliver Klein (BIH Center for Regenerative Therapies, Charité), Dr. Uli Ohmayer (NEOsphere), Dr. Nicolas Pythoud (Novartis), Dr. Yasemin Uçal and Dr. Alexandra Iakab (CeMOS) who will be presenting their state-of-the-art scientific research.
Curious about newest insights in the field of biomarker discovery with innovative proteomics, immunopeptidomics, metabolomics and lipidomics approaches as well as RNA characterization? Then you cannot miss the presentations of Prof. Dr. Stefan Tenzer (University Medical Center Mainz), Dr. Carla Newman (GSK), Dr. Laura Bindila (University Medical Center Mainz), Dr. Frank Fischer (Merck Group) and Prof. Dr. Carsten Hopf (CeMOS).
The 2-day in-person event is held in a safe, comfortable environment where you can meet and learn from the leading scientist in the pharmaceutical industry and academia.
Reserve your free seat by clicking the registration link below.
Where: MAFINEX Technologiezentrum, 68163 Mannheim, Germany.
Webinar: Monitoring small molecules from a colon cancer spheroid model in 3D using MALDI MSI
November 29, 2022 - 10:00 am - 11:00 am CET
The globally marketed webinar is organized by our M2Aind partner company Bruker and chaired by Dr. Janina Oetjen.
Speaker
Prof. Dr. Carsten Hopf - Stefania-Alexandra Iakab, Ph.D., CeMOS, Mannheim of Applied Sciences will present key results from her work(with the teams of Prof. dr. Rüdiger Rudolf, Prof. Dr. Ivo Wolf, Prof. Dr. Matthias Rädle, Prof. Dr. Julian Reichwald and many others) on MS imaging of 3D-culture models in the M2Aind project “Drugs4Future”with Merck.
Please register here:
https://lnkd.in/ez8CgMzi
More information about the webinar you can find here:
https://lnkd.in/eB-UZBp4
European Pharma Days 2022
Bruker's and M2Aind's 3rd Mass Spectrometry Innovations in Pharma Meeting
Join several industry leaders from top pharma around the globe as they present their perspectives on advanced MS based technologies like trapped ion mobility and MALDI Imaging and how these new technologies are transforming drug discovery.
When? Wednesday, April 27th and Thursday, 28th 2022
Where? Technische Hochschule Mannheim, Aula, Paul-Wittsack-Strasse 10, 68163 Mannheim, Germany
This 2-day event will cover applications within:
Seminar Sessions
Day 1: April 27, 2022, 10:00 am – 19:00 pm:Biologics Characterization
Prof. Dr. Matthias Mann, Director, Department of Proteomics and Signal Transduction, Max-Planck-Institute of Biochemistry, Martinsried, German
Day 2: April 28, 2022, 9:00 am – 17:00 pm: MALDI Imaging
Dr. Peter Marshal, Principal Research Analyst, GlaxoSmithKline, Stevenage, United Kingdom
The event is held in a safe, comfortable environment where you can meet and learn from the leading scientist in the pharmaceutical industry and academia. Organized by Bruker, M2Aind and CeMOS – Center for Mass Spectrometry and Optical Spectroscopy.
Reserve your free seat by clicking the registration link below.
Please click here for more information.
M2Aind-Talk-Live meets MEDTECHON-SITE
Online-Veranstaltung
Wann: 25.6.2020, 12.00 bis 14.30 Uhr
Teil 1
M2Aind TalkLive
Thema: "Messtechnische Horizonte für Medizin und Chemie"
Spannende Webinar-live-Vorträge:
1. Julian Deuerling, CeMOS, Technische Hochschule Mannheim
Messtechnische Horizonte in der chemisch-pharmazeitischen Industrie und Messtechnik
2. Dr. Jens Nolte Eckhardt, Tec5 AG
Anforderungen an und Lösungsansätze mit spektroskopischen in-line-Prozess-Sensoren für die Industrie 4.0: Anwendungen in der chemischen und pharmazeutischen Industrie
3. Dr. Jochen Friedemann und Daniel Schock-Kusch, MediBeacon GmbH
Fluoreszierende Organfunktionsmarker: Minimalinvasive Messung wichtiger Vitalfunktionen und klinischer Parameter
Teil 2
Live-Stream der Stadt Mannheim "MEDTECHON-SITE"
MEDTECHON-SITE – Live aus dem Bruker Rhine-Neckar Center im Forschungszentrum CeMOS“. Bei einem Rundgang durch das Bruker Zentrum informiert die Stadt Mannheim über die Möglichkeiten der Zusammenarbeit zwischen der Technischen Hochschule Mannheim und Unternehmen und werden einige Industrieprojekte der Innovationspartnerschaft M²Aind vorstellen. Moderation: Dr. Elmar Bourdon, Stadt Mannheim
Bitte melden Sie sich unter: medtech@mannheim.de zu den Veranstaltungen an. Geben Sie bitte bei der Anmeldung an, ob Sie an beiden bzw. an welcher der Veranstaltungen Sie gern teilnehmen möchten.
Bioanalytics of Biopharmaceuticals (BOB)
Biannual exchange of experiences with short talks
When: Tuesday, 5.11.2019, 3pm to 5:25 p.m. (till 7 for hard networkers)
Where: Technische Hochschule Mannheim, Karl-Völker-Saal, 4th floor, building A, Speyerer Straße 2-4, 68163 Mannheim
Tuesday, November 5, 2019 and come to our biannual exchange of Solutions for Challenges in Bioanalytics of Biopharmaceuticals incl. short impulse talks.
We are very happy to welcome the following speakers of the health industry at our event:
1. Dr. Soraya Hölper, Sanofi, Frankfurt
2. Dr. Thomas Schirrmann, CEO, Yumab GmbH, Braunschweig
3. Prof. Dr. Peter Findeisen, MVZ Labor Dr. Limbach & Kollegen, Heidelberg
4. Dr. Christian Albers (requested), Bruker Daltonik GmbH, Bremen
If you would like to register immediately, please send us an e-mail: m2aind@hs-mannheim.de
More information will follow shortly.
Smart Drug Development & Design from Candidate to Phase I
When: April 4 I 9:30am – 2:15pm
Where: Conference Center Technology Park, Im Neuenheimer Feld 582, Heidelberg
This event will focus on key considerations for transitioning a molecule from discovery to phase 1 readiness including API and formulation development, pharmacokinetics, quality and CMC requirements, and incorporation of clinical supply services solutions to meet protocol, clinical site and patient needs.
Here you will find the Programm. More information will be available here.
Please register for the free Seminar here.
Following the meeting, all Catalent speakers and executives will be available for private, no-obligation discussions on specific programmes and challenges. To request an appointment, please contact Annalisa Zuccotti (az@biorn.org).
Hinweis: M²Aind ist bei dieser Veranstaltung nicht involviert. Es handelt sich hier um eine Anküdigung der Veranstaltung.
Bioanalytics of Biopharmaceuticals (BOB)
Biannual exchange of experiences with short talks
When: Tuesday, 2.4.2019, 3pm to 6pm
Where: Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt
In person and on behalf of our co-organizer Merck KGaA, we cordially invite you to our second event biannual Exchange of Solutions for Challenges in Bioanalytics of Biopharmaceuticals with Keynote Speeches in the Bioanalytics of Biopharmaceuticals Division.
We present you
Short talks
- Dr. Friedrich Reinhard, Cellzome, a GSK Company - Chemoproteomics and Thermal Protein Profiling in Target Discovery and Validation
- Dr. Christian Lutz, Heidelberg Pharma Research GmbH - Analytical characterization of antibody-amatoxin conjugates (ADCs)
- Dr. Sibylle Heidelberger, AB Sciex Germany GmbH - Development of High Throughput Online Native LC/MS
Please register until March 18th, 2019 at the following e-mail address: m2aind@hs-mannheim.de. Further details will be provided after your registration. We would be very pleased about your participation.
Mass Spectrometry and Surface Plasmon Resonance (SPR) Innovations in Pharma
Join several industry leaders from top pharma companies and academia around the globe as they present their perspectives on using advanced MS and SPR based technologies to streamline the drug development process. From lead generation all the way through to pre-clinical assessment, Bruker has built on years of excellence in Mass Spectrometry to impact the pharmacological related industry far beyond the traditional role of quantitation and process monitoring.
Seminar sessions
March 18, 2019 // 9.30 am - 6.30 pm
rapifleX MALDI Pharma Pulse, timsTOF Pro (trapped ion mobility) and SPR-32 (surface plasmon resonance) applications in Pharma
March 19, 2019 // 9 am - 4 pm
MS Imaging Applications in Pharma
Get more information here.
5. M²Aind Talk am Dienstag, den 19. Februar 2019 von 16.00 Uhr bis 19.00 Uhr
Wir freuen uns, dass der M²Aind Talk zum ersten Mal außer Haus stattfindet und wir zu Gast bei der IHK Rhein-Neckar in Heidelberg sein werden. Wir bedanken uns recht herzlich bei der IHK Rhein-Neckar für die Unterstützung und Gastfreundschaft. Bei diesem M²Aind Talk beschäftigen sich die drei Impulsvorträgen - angelehnt an das Impulsprojekt SM²all - mit dem Thema Chemische Analytik mit Ionenmobilitätsspektrometrie und Wirkstofftestung in Assays.
Programm:
16.00 Uhr Empfang
16.30 Uhr Begrüßung
16.40 Uhr Vorträge:
GC-IMS – Selektive Spurengasanalyse von flüchtigen Verbindungen in industriellen Anwendungen
Thomas Wortelmann, G.A.S. Gesellschaft für analytische Sensorsysteme mbH
Ansätze zur Quantifizierung von Terpenen aus komplexen Gemischen mittels zweidimensionaler GC-IMS und MCR-ALS
Prof. Dr. Philipp Weller / Rebecca Brendel, Innovationspartnerschaft M²Aind
Discovery of potent inhibitors of the hepatic & intestinal drug transporter OATP2B1 through a cell based fluorescence assay
Melissa Unger, Innovationspartnerschaft M²Aind
17.30 Uhr Networking bei Fingerfood und Drinks
Ca. 19.00 Uhr Ende der Veranstaltung
Bitte melden Sie sich bis zum 10. Februar 2019 unter folgender E-Mail Adresse an: m2aind@hs-mannheim.de
Adresse:
IHK Rhein-Neckar
Theodor Frey Saal
Hans-Böckler-Straße 4
69115 Heidelberg
Bitte beachten Sie, dass die IHK Rhein-Neckar keine Parkmöglichkeiten anbietet. Es befinden sich aber zahlreiche Parkhäuser in der Nähe. Auch mit den öffentlichen Verkehrsmitteln ist die IHK Rhein-Neckar gut zu erreichen. Eine Anfahrtsskizze finden Sie hier.
Parken:
Parkhaus Poststraße, Poststraße 7-9, 69115 Heidelberg
Parkhaus Bauhaus, Bahnhofstraße 4, 69115 Heidelberg
Parkhaus Europäischer Hof, Friedrich-Ebert-Anlage 1, 69117 Heidelberg
Anfahrt mit öffentlichen Verkehrsmitteln:
Sie erreichen uns mit allen öffentlichen Verkehrsmitteln: Haltestelle Bismarckplatz
Bioanalytics of Biopharmaceuticals (BOB)
Biannual exchange of experiences with short talks
When: Tuesday, 9.10.2018, 4pm to 7pm
Where: Technische Hochschule Mannheim, Karl-Völker-Saal, 4th floor, building A, Speyerer Straße 2-4, 68163 Mannheim
- 4:00 pm - Networking with coffee and cake
- 4:30 pm - Welcome and introduction to the topic Bioanalytics of Biopharmaceuticals and Introduction M²Aind, Dr. Roland Kellner Merck KGaA, Darmstadt and Prof. Dr. Carsten Hopf, Center forMass Spectrometry and Optical Spectroscopy (CEMOS)
- 4:45 pm - ADCs: Searching for the magic bullet | Dr. Jan Anderl, Merck KGaA, Darmstadt
- 5:10 pm - Developing First-In-Class Immune Cell Engagers for the Activation of Innate and Adaptive Immunity to Fight Cancer, Thomas Müller, Affimed GmbH, Heidelberg
- 5:35 pm- LC-MALDI analysis of biopharmaceuticals: A real strange idea or a solution to current issues with potential? Dr. Detlev Suckau, Bruker Daltonik GmbH, Bremen
- 5:50 pm - Networking with food and drinks
Please register atm2aind@hs-mannheim.de
2. M²Aind Talk
Am 17. April 2018 veranstaltete die Innovationspartnerschaft M²Aind den 2. M²Aind Talk. Dabei handelt es sich um ein Get-Together der Gesundheitsindustrie für den Großraum Rhein-Main-Neckar.
Es wurden drei Impulsvorträge zum Thema „Prozessentwicklung und Prozessanalytik“ gehalten:
Intro: Herr Dr. Siegfried Bialojan, Ernst & Young GmbH
Herr Stefan Bley, Ernst & Young GmbH, Industry 4.0 – Smart Production
Herr Prof. Dr. Thorsten Röder, Technische Hochschule Mannheim, Mehrphasenreaktion in Mikroreaktoren
Herr Thomas Müller und Herr Ralf Stegemann, EM-Technik GmbH, Innovation in Kunststoff
Wir bedanken uns bei der E&Y Wirtschaftsprüfungsgesellschaft für die freundliche Unterstützung.
MALDI Innovations in Pharma Feb 21 & 22, 2018
Bruker Daltonics and the M2Aind Partnership for Innovation in Health Industry are organizing a two-day workshop on “MALDI Innovations in Pharma”, which shall take place on Feb 21st/22nd in Mannheim.
The first day will focus onrapifleX PharmaPulse – MALDI MS-based assays for compound profiling incl HTS. Day 2 will feature current applications in pharma industry and in chemical biology.
Please, register via the Bruker website.
Seminar Sessions
February 21: rapifleX MALDI PharmaPulse: reset your expectation for label-free high-throughput-screening utilizing mass spectrometry
February 22: MS Imaging Applications in Pharma and Chemical Biology
1. M²Aind Talk
Ihr Branchentreff der Gesundheitsindustrie für den Großraum Rhein-Neckar-Main
Der M²Aind Talk ist ein Get-Together der Gesundheitsindustrie für den Großraum Rhein-Neckar-Main. Vertreter der regionalen Gesundheitsindustrie nutzen die Gelegenheit sich auszutauschen und Neues aus der Industrie zu erfahren.
Wo: Karl Völker Saal, Gebäude A, Technische Hochschule Mannheim
Wann: 20.11.2017 von 16.00 Uhr bis 19.00 Uhr
Es erwarten Sie spannende Impulsvorträge:
- Prof. Dr. Marcus Rieker - Horiba Europe GmbH
- Prof. Dr. Matthias Rädle, M2Aind - Technische Hochschule Mannheim
- Prof. Dr. Carsten Hopf, M2Aind - Technische Hochschule Mannheim
Programmpunkte
16:00 Uhr Empfang und Beginn
16.30 Uhr Begrüßung und Short Talks
17.30 Uhr Networking
Bitte melden Sie sich unter folgender E-Mail Adresse an: m2aind@hs-mannheim.de
BIORN ANNUAL CONFERENCE 2017
REVOLUTION THROUGH CONVOLUTION – COMBINING MEDTECH, BIOTECH AND DIGITAL HEALTH TO PROMOTE HEALTH SCIENCE IN OUR REGION
Die diesjährige BioRN-Jahrestagung am 24.10.2017, bietet erneut ein abwechslungsreiches Programm und zahlreiche Möglichkeiten zu Vernetzung. Neben Fachvorträgen zum Tagungsthema gibt es für BioRN-Mitglieder die Möglichkeit, ihr Projekt oder Unternehmen im Rahmen von Kurzvorträgen vorzustellen. Das Programm wird durch eine Posterausstellung abgerundet.
Bei den bisher bestätigten Sprecher/innen handelt es sich um:
Clemens Suter-Crazzolara (SAP)
Elmar Bourdon (Medtech Cluster Mannheim)
Nico Stam (Health Axis Europe Partner, Brightlands Maastricht Health Campus)
Gitte Neubauer (Cellzome, a GSK company)
Andrée Rothermel (Ci3)
Kai Gräber (Ci3)
Wulf Fischer-Knuppertz (BIOCRATES Life Sciences AG)
Prof. Carsten Hopf (Technische Hochschule Mannheim)
Prof. Rüdiger Rudolf (Technische Hochschule Mannheim)
Weitere Informationen zur Veranstaltung finden Sie hier.
